Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Neurological Sciences

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 3225630
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention

  2004cited by this paper
• Progressive muscular dystrophy in a golden retriever dog: light microscope and ultrastructural features at 4 and 8 months

  2004cited by this paper
• Muscular dystrophy in a litter of golden retriever dogs

  1988cited by this paper
• The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs

  1988cited by this paper
• Canine muscular dystrophy: confirmation of X-linked inheritance.

  1988cited by this paper
• Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

  1987cited by this paper
• The clinical consequences of X-chromosome inactivation: Duchenne muscular dystrophy in one of monozygotic twins.

  1987cited by this paper
• Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles.

  1987cited by this paper
• The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates.

  1987cited by this paper
• Practical analysis of variability of muscle function measurements in duchenne muscular dystrophy

  1987cited by this paper
• Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency: a five years follow-up.

  1986cited by this paper
• A mathematical analysis of creatine kinase activity in the course of duchenne muscular dystrophy

  1986cited by this paper
• Muscular dystrophy in girls with X;autosome translocations.

  1986cited by this paper
• Xp21/autosome translocations

  1986cited by this paper
• Clinical features in a girl with Duchenne muscular dystrophy with an X-autosome translocation; (X;4)(p21;q26).

  1986cited by this paper
• Linkage studies in Duchenne and Becker muscular dystrophies.

  1986cited by this paper
• Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy

  1985cited by this paper
• Prospective study of X‐linked progressive muscular dystrophy in campania

  1983cited by this paper
• Observations on Normal Skeletal Muscle of Mature Dogs: A Cytochemical, Histochemical, and Morphometric Study

  1982cited by this paper
• Clinical biochemistry of muscular dystrophy.

  1980cited by this paper
• Biochemistry of muscle membranes in Duchenne muscular dystrophy

  1980cited by this paper
• Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis.

  1980cited by this paper
• The heart in muscular dystrophy.

  1980cited by this paper
• Morphological changes in dystrophic muscle.

  1980cited by this paper
• Clinical features and classification of the muscular dystrophies.

  1980cited by this paper
• NEUROMUSCULAR DISEASES OF DOMESTIC ANIMALS: A SUMMARY OF MUSCLE BIOPSIES FROM 159 CASES *

  1979cited by this paper
• Structure of the canine oesophagus.

  1973cited by this paper
• Myopathy with a Possible Recessive X-Linked Inheritance in a Litter of Irish Terriers

  1972cited by this paper
• Myopathies in the dog.

  1958cited by this paper

• Exploring Desmin as a Potential Modifier in Duchenne Muscular Dystrophy–Associated Cardiomyopathy

  2025cites this paper
• Cardiac Cell and Animal Models for Duchenne Muscular Dystrophy in the Era of Gene Therapy and Precision Medicine

  2025cites this paper
• Respiratory performance in Duchenne muscular dystrophy: Clinical manifestations and lessons from animal models

  2024cites this paper
• Uncovering the Embryonic Origins of Duchenne Muscular Dystrophy.

  2024cites this paper
• Intragenic dystrophin (DMD) duplication variant in Entlebucher Mountain Dogs with Duchenne muscular dystrophy.

  2024cites this paper
• Specific and label-free endogenous signature of dystrophic muscle by Synchrotron deep ultraviolet radiation

  2023cites this paper
• Generation of a Dystrophin Mutant in Dog by Nuclear Transfer Using CRISPR/Cas9-Mediated Somatic Cells: A Preliminary Study

  2022cites this paper
• CRISPR-Based Therapeutic Gene Editing for Duchenne Muscular Dystrophy: Advances, Challenges and Perspectives

  2022cites this paper
• Serum inflammatory cytokines as disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy

  2022cites this paper
• Comparison of dystrophin expression following gene editing and gene replacement in an aged preclinical DMD animal model.

  2022cites this paper
• Genetically modified animal models of hereditary diseases for testing of gene-directed therapy

  2022cites this paper
• The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy

  2022cites this paper
• Lower Motor Neuron

  2021cites this paper
• Generation of a dystrophin mutant dog by nuclear transfer using CRISPR/Cas9-mediated somatic cells

  2021cites this paper
• A Dystrophin Exon-52 Deleted Miniature Pig Model of Duchenne Muscular Dystrophy and Evaluation of Exon Skipping

  2021influential citation
• Model Animals Development of outcome measures according to dystrophic phenotypes in canine 3 X-linked muscular dystrophy in Japan 4

  2021influential citation
• Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength

  2021cites this paper
• Animal models for researching approaches to therapy of Duchenne muscular dystrophy

  2021cites this paper
• Musculoskeletal magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy

  2021cites this paper
• Development of outcome measures according to dystrophic phenotypes in canine X-linked muscular dystrophy in Japan

  2021cites this paper
• Uncontrolled Involuntary Skeletal Muscle Contractions

  2021cites this paper
• Muscular dystrophy: Experimental animal models and therapeutic approaches (Review)

  2021cites this paper
• Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases

  2020cites this paper
• Australian Labradoodle Dystrophinopathy: A Novel Canine Model for the Study of Duchenne Muscular Dystrophy Cardiomyopathy

  2020cites this paper
• X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation

  2020cites this paper
• “Betwixt Mine Eye and Heart a League Is Took”: The Progress of Induced Pluripotent Stem-Cell-Based Models of Dystrophin-Associated Cardiomyopathy

  2020cites this paper
• COL6A1 related muscular dystrophy in Landseer dogs: A canine model for Ullrich congenital muscular dystrophy

  2020cites this paper
• X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterization.

  2020cites this paper
• Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine

  2020cites this paper
• Widespread severe myodegeneration in a compound heterozygote female dog with dystrophin deficiency

  2020cites this paper
• The panniculus carnosus muscle: A novel model of striated muscle regeneration that exhibits sex differences in the mdx mouse

  2019cites this paper
• Mutation-Based Therapeutic Strategies for Duchenne Muscular Dystrophy: From Genetic Diagnosis to Therapy

  2019influential citation
• The Dog Model in the Spotlight: Legacy of a Trustful Cooperation

  2019cites this paper
• Animal Models for Muscle Disease and Muscle Gene Therapy

  2019cites this paper
• CRISPR Correction of Duchenne Muscular Dystrophy.

  2019cites this paper
• Pathological Issues in Dystrophinopathy in the Age of Genetic Therapies.

  2019cites this paper
• Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing.

  2018cites this paper
• Expression profiling of disease progression in canine model of Duchenne muscular dystrophy

  2018cites this paper
• Morphological Characterization of the Myenteric Plexus of the Ileum and Distal colon of Dogs Affected by Muscular Dystrophy

  2018cites this paper
• Tackling muscle fibrosis: From molecular mechanisms to next generation engineered models to predict drug delivery.

  2018cites this paper
• Dysphagia and esophageal dysfunction due to dystrophin deficient muscular dystrophy in a male Spanish water spaniel

  2018cites this paper
• a Investigating sodium-hydrogen exchanger 1 (NHE1) inhibition as a potential therapy for Duchenne muscular dystrophy

  2018cites this paper
• Cycles of myofiber degeneration and regeneration lead to remodeling of the neuromuscular junction in two mammalian models of Duchenne muscular dystrophy

  2018cites this paper
• Handbook of Laboratory Animal Science Animal Models

  2018cites this paper
• Sex influences diaphragm muscle response in exercised mdx mice

  2018cites this paper
• Animal Models for Tropical Parasitic Diseases

  2018cites this paper
• Characterization of Australian Labradoodle dystrophinopathy.

  2018cites this paper
• A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9

  2018cites this paper
• Nitric oxide‐dependent attenuation of noradrenaline‐induced vasoconstriction is impaired in the canine model of Duchenne muscular dystrophy

  2018cites this paper
• Relevant aspects of golden retriever muscular dystrophy for the study of Duchenne muscular dystrophy in humans

  2017influential citation
• Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy

  2017cites this paper
• Canine and Feline Models of Human Genetic Diseases and Their Contributions to Advancing Clinical Therapies


  2017cites this paper
• MOLECULAR SCREENING OF FOUR CANINE HEREDITARY DISEASES IN TAIWAN

  2017cites this paper
• Non-Targeted Metabolomics Analysis of Golden Retriever Muscular Dystrophy-Affected Muscles Reveals Alterations in Arginine and Proline Metabolism, and Elevations in Glutamic and Oleic Acid In Vivo

  2017cites this paper
• Effects of hyperlipidemia on dysferlin- and dystrophin-deficient muscular dystrophies in double-disease mouse models

  2017cites this paper
• Immunohistochemical analysis of canine and feline muscle disorders using formalin-fixed, paraffin-embedded tissues

  2017cites this paper
• Dual AAV Gene Therapy for Duchenne Muscular Dystrophy with a 7-kb Mini-Dystrophin Gene in the Canine Model

  2017cites this paper
• Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells

  2017cites this paper
• The golden retriever model of Duchenne muscular dystrophy

  2017cites this paper
• Increased collagen cross‐linking is a signature of dystrophin‐deficient muscle

  2016cites this paper
• Whole genome sequencing reveals a 7 base-pair deletion in DMD exon 42 in a dog with muscular dystrophy

  2016cites this paper
• TITLE : Use of the Six-Minute Walk Test to Characterize Golden Retriever Muscular Dystrophy AUTHOR ( S ) NAMES AND AFFILIATION :

  2016cites this paper
• Development of the cardiorespiratory system in dogs from days 16 to 46 of pregnancy.

  2016cites this paper
• Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy

  2016cites this paper
• Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells

  2016cites this paper
• Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.

  2016cites this paper
• Canine-Inherited Dystrophinopathies and Centronuclear Myopathies

  2016cites this paper
• Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs.

  2016cites this paper
• Use of the six-minute walk test to characterize golden retriever muscular dystrophy.

  2016cites this paper
• The function of Activin receptor type IIb signaling in adult skeletal muscle

  2016cites this paper
• Role of vascular plasticity in muscle remodeling in the child

  2015cites this paper
• Engineering and optimisation of mini-dystrophin constructs for Duchenne muscular dystrophy gene therapy

  2015cites this paper
• Intra-amniotic rAAV-mediated microdystrophin gene transfer improves canine X-linked muscular dystrophy and may induce immune tolerance.

  2015cites this paper
• Multiscale models of skeletal muscle reveal the complex effects of muscular dystrophy on tissue mechanics and damage susceptibility

  2015cites this paper
• Why is the dog an ideal model for aging research?

  2015cites this paper
• A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy

  2015cites this paper
• Profiles of Steroid Hormones in Canine X-Linked Muscular Dystrophy via Stable Isotope Dilution LC-MS/MS

  2015cites this paper
• Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First‐Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs

  2015cites this paper
• Methods to Induce Cardiac Hypertrophy and Insufficiency

  2015cites this paper
• TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy.

  2015cites this paper
• MAPK Pathway MAPK Pathway in Skeletal Muscle Diseases

  2015cites this paper
• Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation

  2015cites this paper
• Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy

  2015influential citation
• Duchenne Muscular Dystrophy Gene Therapy in the Canine Model

  2015cites this paper
• MRI texture analysis of GRMD dogs using orthogonal moments: A preliminary study

  2015cites this paper
• Clinical Phenotype of X‐Linked Myotubular Myopathy in Labrador Retriever Puppies

  2015cites this paper
• Early loss of ambulation is not a representative clinical feature in Duchenne muscular dystrophy dogs: remarks on the article of Barthélémy et al.

  2015influential citation
• Dystrophin-deficient large animal models: translational research and exon skipping.

  2015influential citation
• Dystrophin-deficient muscular dystrophy in a Norfolk terrier.

  2015cites this paper
• Small and large animal models in cardiac contraction research: advantages and disadvantages.

  2014cites this paper
• Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy

  2014cites this paper
• Influence of Immune Responses in Gene/Stem Cell Therapies for Muscular Dystrophies

  2014cites this paper
• Respiratory dysfunction in unsedated dogs with golden retriever muscular dystrophy.

  2014influential citation
• Morphological and ultrastructural evaluation of the golden retriever muscular dystrophy trachea, lungs, and diaphragm muscle

  2014cites this paper
• Stem Cells in Dystrophic Animal Models: From Preclinical to Clinical Studies

  2014cites this paper
• Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

  2014cites this paper
• Stem Cells in Animal Species: From Pre-clinic to Biodiversity

  2014cites this paper
• Mapping contrast agent uptake and retention in MRI studies of myocardial perfusion: case control study of dogs with Duchenne muscular dystrophy

  2013cites this paper
• Initial Pulmonary Respiration Causes Massive Diaphragm Damage and Hyper-CKemia in Duchenne Muscular Dystrophy Dog

  2013cites this paper
• MAPK Pathway in Skeletal Muscle Diseases

  2013cites this paper